You might not have heard of ipilimumab and nivolumab before, and that’s okay, but these two immunotherapy drugs could be the future of skin cancer treatment. Studies have shown that a new treatment using both of these drugs together can clear melanoma skin cancer tumours in 22 percent of cases.
While the drugs have been used separately in the past, scientists now think that using them together could be much more effective. In a recent trial involving 142 patients, where both drugs were used as treatment, 69 percent of patients were still alive after two years, compared with 53 percent who were using ipilimumab alone.
From our very good friends over at sciencealert.com
Click Here for the Full Article